Deferasirox for Porphyria Cutanea TardaDeferasirox for Porphyria Cutanea Tarda
A small pilot study offers promise for an alternative to phlebotomy in the treatment of this systemic and dermatologic disease. Medscape Dermatology (Source: Medscape Today Headlines)
Deferasirox (marketed as Exjade, Desirox, Defrijet, Desifer...) is an iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose. Deferasirox
Deferasirox (marketed as Exjade, Desirox, Defrijet, Desifer...) is an iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose. Deferasirox
ReplyDelete